Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Carl Zeiss Meditec AG    AFX   DE0005313704

CARL ZEISS MEDITEC AG

(AFX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • The company has poor fundamentals for a short-term investment strategy.
Strengths
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • The stock is in a well-established, long-term rising trend above the technical support level at 95.3 EUR
Weaknesses
  • The share is close to its long-term resistance in weekly data. Therefore, the potential should be limited. However, a further bullish movement when crossing this resistance will be a positive signal.
  • The stock is currently in contact with a medium-term resistance that must be gotten rid of so as to resume the upward trend.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 78.22 times its estimated earnings per share for the ongoing year.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • For the last few months, analysts have been revising downwards their earnings forecast.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
Ratings chart
Sector Advanced Medical Equipment & Technology - NEC
1st jan.Capitalisation (M$)Investor Rating
CARL ZEISS MEDITEC AG-3.69%11 420
THERMO FISHER SCIENTIFIC45.25%188 581
DANAHER CORPORATION49.90%164 879
INTUITIVE SURGICAL, INC.16.09%80 855
SHENZHEN MINDRAY BIO-MEDICA..117.15%67 575
BOSTON SCIENTIFIC CORPORATI..-25.92%48 743
SIEMENS HEALTHINEERS AG-14.34%46 460
EDWARDS LIFESCIENCES CORPOR..-6.24%45 659
ILLUMINA, INC.-5.08%45 326
KONINKLIJKE PHILIPS N.V.-5.94%43 292
AGILENT TECHNOLOGIES, INC.19.59%31 343
RESMED, INC.15.84%26 179
OLYMPUS CORPORATION16.37%24 339
CERNER CORPORATION-3.97%21 572
HOLOGIC, INC.35.03%18 049
VARIAN MEDICAL SYSTEMS, INC..21.32%15 717
More Results
Financials
Sales 2020 1 372 M 1 604 M 1 604 M
Net income 2020 121 M 141 M 141 M
Net cash 2020 556 M 651 M 651 M
P/E ratio 2020 78,2x
Yield 2020 0,50%
Capitalization 9 794 M 11 420 M 11 449 M
EV / Sales 2020 6,73x
EV / Sales 2021 6,16x
Nbr of Employees 3 335
Free-Float 40,9%
Upcoming event on CARL ZEISS MEDITEC AG
Notations Surperformance©
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes